Bortezomib-Dexamethasone-Doxorubicin-Study

Mise à jour : Il y a 4 ans
Référence : NCT00401804

Femme et Homme

Extrait

The primary objective of the study is to evaluate the activity of BDD in subjects with acute renal failure as measured by· reversal of acute renal failureSecondary objectives· tumor response (complete and partial response)· To evaluate the safety of Bortezomib- Doxorubicin-Dexamethasone in this patient population· to evaluate the activity of Bortezomib- Doxorubicin -Dexamethasone on progression free survival · to evaluate the activity of Bortezomib- Doxorubicin -Dexamethasone on overall survival


Critère d'inclusion

  • Multiple myeloma ,Renal Insuficiency

Liens